Wednesday, January 27, 2021
  • Home
  • Lifestyle
  • Health
  • Tourism & Travel
  • Sports
  • Music
  • Politics
  • Community
    • Agriculture
  • Business
    • SME’s
  • Gallery
Zimbabwe News Newsdzezimbabwe
VAYA
  • Home
  • Lifestyle
  • Health
  • Tourism & Travel
  • Sports
  • Music
  • Politics
  • Community
    • Agriculture
  • Business
    • SME’s
  • Gallery
No Result
View All Result
Zimbabwe News Newsdzezimbabwe
  • Home
  • Lifestyle
  • Health
  • Tourism & Travel
  • Sports
  • Music
  • Politics
  • Community
    • Agriculture
  • Business
    • SME’s
  • Gallery
No Result
View All Result
Zimbabwe News Newsdzezimbabwe
No Result
View All Result

First alternative pneumonia vaccine breaks Pfizer and GSK’s decades-long stranglehold

Byron Adonis Mutingwende by Byron Adonis Mutingwende
December 23, 2019
in Business, Community, Development, Health
0
First alternative pneumonia vaccine breaks Pfizer and GSK’s decades-long stranglehold
Pneumococcal conjugate vaccine

The World Health Organization (WHO) has just quality assured a third pneumococcal conjugate vaccine (PCV), manufactured by the Serum Institute of India, that protects children against certain types of pneumonia and will be much more affordable than existing vaccines. This critical step will enable countries and treatment providers to procure more affordable versions of the vaccine, which has long been out of reach for millions of children because of the high prices of the existing vaccines produced by Pfizer and GlaxoSmithKline (GSK). This is the first pneumococcal vaccine produced by a developing country manufacturer. The Bill & Melinda Gates Foundation provided some pioneering support for the development of the vaccine.

Until now, pharmaceutical corporations Pfizer and GSK have maintained a duopoly on the vaccine for nearly 20 years* that has allowed them to keep prices high. Pfizer and GSK charge Gavi, the Vaccine Alliance – a donor-funded organisation that helps the poorest countries access vaccines – roughly R130 for each child to be vaccinated in the poorest countries, and as much as R1 140 per child for middle-income countries that don’t qualify for Gavi support. There is little transparency on the prices charged by Pfizer and GSK, as the corporations take great lengths to keep prices secret. The result of these high prices is that governments cannot afford the vaccine, and children are left unprotected against deadly diseases like pneumonia.

Pfizer and GSK have earned over R700 billion in sales of the pneumococcal vaccine in the past ten years, with Pfizer winning the lion’s share of these revenues. Today, 55 million children around the world still do not have access to the pneumonia vaccine, largely due to high prices.

The Serum Institute of India has stated previously that they plan to sell the vaccine at about R85 per child to Gavi and to the poorest countries, and for no more than about R157 in middle-income countries, significantly less than Pfizer and GSK’s products.

Governments that wish to purchase this new more affordable vaccine should consider using the WHO Collaborative Registration Procedure to accelerate its registration.

 

Quote by Kate Elder, Senior Vaccines Policy Advisor for MSF’s Access Campaign:

“This is a monumental day for kids around the world and the governments that are trying to protect them from life-threatening pneumonia. A more affordable pneumonia vaccine is a gamechanger in protecting more children against the world’s number one childhood killer.

MSF has been calling for a more affordable pneumonia vaccine for years, asking that it be priced at no more than R70 per child. This new and more affordable vaccine from an Indian manufacturer will finally break the longstanding stranglehold by pharmaceutical corporations Pfizer and GSK, meaning that the more than 55 million kids around the world that have been left out largely due to corporate greed can finally have a fair shot at being protected. Many of these children reside in countries deemed ‘middle-income,’ who cannot benefit from special prices negotiated by Gavi.

To save as many lives as possible, we call on WHO, UNICEF and Gavi to step-up and help governments access this more affordable vaccine as rapidly as possible. We also expect the Serum Institute of India to extend the lowest global price for its new pneumonia vaccine to all humanitarian organisations.”

Tags: Pneumonia vaccine
Previous Post

AU “Silence the Guns” to be realized as communities and Heads of State rally around the DPCW

Next Post

Rethinking the control of transboundary plant pests and diseases

Byron Adonis Mutingwende

Byron Adonis Mutingwende

Related Posts

Finding strengths in local food markets amid the pandemic
Pneumococcal conjugate vaccine
Agriculture

Finding strengths in local food markets amid the pandemic

by Byron Adonis Mutingwende
January 26, 2021
Rosemary’s story: Passion for saving lives remains undimmed by COVID-19
Pneumococcal conjugate vaccine
Business

Rosemary’s story: Passion for saving lives remains undimmed by COVID-19

by Byron Adonis Mutingwende
January 26, 2021
New Report: African media shows western sources dominate how the Africa story is told
Pneumococcal conjugate vaccine
Business

New Report: African media shows western sources dominate how the Africa story is told

by Byron Adonis Mutingwende
January 26, 2021
Mauritania a signatory of Establishment Agreement of Fund for Export Development in Africa
Pneumococcal conjugate vaccine
Business

Mauritania a signatory of Establishment Agreement of Fund for Export Development in Africa

by Byron Adonis Mutingwende
January 26, 2021
MuDealer hits the music industry with a bang
Pneumococcal conjugate vaccine
Arts and culture

MuDealer hits the music industry with a bang

by Byron Adonis Mutingwende
January 26, 2021
Next Post
Rethinking the control of transboundary plant pests and diseases
Pneumococcal conjugate vaccine

Rethinking the control of transboundary plant pests and diseases

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search Here

No Result
View All Result
TelOne
Maisha
BankABC
Maisha

About Spiked Online Media

Latest Zimbabwe news , newsdzezimbabwe with spiked catch all breaking news 24 hours online media  platform.

Categories

Browse by Tag

Africa African Development Bank Business climate change COVID-19 Cyclone Idai Devices DStv Econet Econet Wireless Zimbabwe education Entertainment Entrepreneurship Explore Bali Gadgets Government Harare Harare City Council Health Human Rights Investments Market Stories mobile money Music NetOne Pan African Parliament partnerships Politics POTRAZ Smartphones social media South Africa sports streaming Strive Masiyiwa Technology Telecommunications Tourism Transportation UN WhatsApp Women youths ZEC zimbabwe
TelOne

Latest Zimbabwe news , newsdzezimbabwe with spiked catch all breaking news 24 hours online media  platform.

ZTA

© 2020 -Spiked Online News & magazine by Web3 Solutions.

No Result
View All Result
  • Home
  • Lifestyle
  • Health
  • Tourism & Travel
  • Sports
  • Music
  • Politics
  • Community
    • Agriculture
  • Business
    • SME’s
  • Gallery

© 2020 -Spiked Online News & magazine by Web3 Solutions.